Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
SOLID ORAL DOSAGE FORMS COMPRISING DECITABINE AND CEDAZURIDINE

No-Receipt date 2024-03848 - 17/10/2024
No-Filing date 20240402431 - 17/10/2024
No-Granting date 3116656 - 29/10/2024
No-EPO application date 21761883.4 - 24/02/2021
No-EPO granting date 4069254 - 11/09/2024
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2024 - 11/11/2024
Expiration date 25/02/2041
Kind of title Validation of European Patent
Legal status VALID
Priorities US202062981304 P25/02/2020/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/706
A61K 31/7068
A61P 35/00
A61P 35/02

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1681538 OTSUKA PHARMACEUTICAL CO., LTD. 2-9, KANDA TSUKASA-MACHI CHIYODA-KUTOKYO 101-8535 JAPAN

Inventors
CodeFirstnameSurname
4399032 OGANESIAN, ARAM
4399033 DAVAR, NIPUN
4399034 KOU, JIM HWAICHER

Representatives
CodeFirstnameSurnameAddressTownZip
3089NIKOLAOSLYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"STOURNARI 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
7915NIKOLAOSLYMPERISSTOURNARI 37ATHINA (ATTIKIS)10682 GREECE

Owners History

Title Instruments

Payments history 5 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015